Updated Monday through Friday
- Drug Firm Annual Registration Status
- Drug Firm Annual Registration Status Download File
- National Drug Code Directory
- NDC Unfinished Drugs Excluded Database File
- NDC Database Excluded Packages and Products
- Wholesale Distributor and Third-Party Logistics Providers Reporting
April 24, 2020
- FDA Drug Shortages
- Ocriplasmin (Jetrea) Injection (New - Discontinuation)
- Sulfasalazine Tablets (New - Currently in Shortage)
- FDA Drug Safety Communication: FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems
- FDA Drug Safety Podcast: FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems
.png)
No hay comentarios:
Publicar un comentario